*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.
Intuitive Surgical's upcoming earnings report is poised to capture attention, particularly as the company continues to solidify its position in the robotic-assisted surgery market. With a market cap nearing $154 billion, Intuitive Surgical's financial health remains robust, and investors are keenly watching for signs of sustained growth. The EPS estimate stands at $2.00, but the whisper number suggests a more optimistic outlook at $2.28, indicating that market insiders may be expecting stronger performance. Revenue is projected at $2.41 billion, reflecting the company's ongoing expansion and innovation in surgical technology. As Intuitive Surgical prepares to release its results on October 21, the focus will be on whether it can exceed these expectations and maintain its momentum in a competitive landscape.
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Website: https://www.intuitive.com
Average Sentiment Score:
Overall Sentiment: